ArticleAlzheimer's & dementia (New York, N. Y.)2022

Use of AD Informer Set compounds to explore validity of novel targets in Alzheimer's disease pathology.

Frances M Potjewyd et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.